In vitro biorelevant dissolution tests enabling the prediction of in vivo performance of an oral modified-release (MR) dosage form were developed in this study.
Ronda, E. +5 more
core
Improvement of XZP8257 Dissolution Properties Through Amorphous and Mixed-Phase Precipitate Formation in Biorelevant Media. [PDF]
Zhang M +6 more
europepmc +1 more source
Integrating Experimental Physicochemical Data with PBPK Modeling to Guide the Translational Development of the Antifungal 1,3,4-Oxadiazole Derivative LMM6. [PDF]
Piai JMB +6 more
europepmc +1 more source
Role of Biorelevant Dissolution Media in the Selection of Optimal Salt Forms of Oral Drugs: Maximizing the Gastrointestinal Solubility and in Vitro Activity of the Antimicrobial Molecule, Clofazimine. [PDF]
Bannigan P +4 more
europepmc +1 more source
Application of New Approach Methodologies to Improve Oral Biopharmaceutic Assessments. [PDF]
García MA +4 more
europepmc +1 more source
An Overview of In Vitro Release Methods for Long-Acting Injectable Products Based on PLGA. [PDF]
Lusina Kregar M, Krtalić I, Šagud I.
europepmc +1 more source
A PBPK-VBE approach for bioequivalence extrapolation of senaparib capsule strengths in the context of nonlinear pharmacokinetics: bridging from the clinical starting dose to the linear pharmacokinetic range. [PDF]
Wu X +10 more
europepmc +1 more source
Chromatographic Characterization of Nasal and Inhalation Drug Products: A Review of Liquid Chromatography Strategies for Formulation Assessment, Particle Size Correlation, and In Vitro Performance Testing. [PDF]
Madamsetti N +3 more
europepmc +1 more source
Development of in vitro-in vivo correlation for establishing patient-centric quality standards of dissolution for lamotrigine extended-release tablets. [PDF]
Zidan A +5 more
europepmc +1 more source
Physiologically Based Biopharmaceutics Modelling-Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary Report. [PDF]
McAllister M +23 more
europepmc +1 more source

